Limited facelift for Facial Asymmetry

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Office of Craig R Dufresne, MD, PC, Fairfax, VA
Facial Asymmetry+2 More
Limited facelift - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

To compare safety, patient satisfaction, and technical correction between a limited and full facelift, patients meeting strict clinical and safety criteria for both types of facelift will be randomly assigned to have one of these procedures. In the context of this study, a limited facelift is done in the office under local anesthesia, and a full facelift is done in the hospital or ambulatory surgical center with either general anesthesia or intravenous sedation.

Eligible Conditions

  • Facial Asymmetry
  • Aging Problems
  • Skin Aging

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: an average of 1 year following surgery

Week 2
Difference between groups in number of patients requiring treatment by surgeon for post-operative adverse effects
1 week following surgery
Difference of "FACE-Q - Recovery Early Symptoms" scores between groups
Year 1
Difference in post-operative aesthetic correction rating between groups
Difference of "FACE-Q | Aesthetics - Adverse Effects: Cheeks, Lower Face, Neck" scores between groups
Difference of "FACE-Q | Aesthetics - Satisfaction with Outcome" scores between groups
Year 1
Change in score of "FACE-Q | Aesthetics - Satisfaction With Lower Face and Jawline" from baseline to last post-operative visit
Difference of "FACE-Q | Aesthetics - Satisfaction With Lower Face and Jawline" baseline and last post-operative visit scores between groups

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Hospital-based full facelift
1 of 2
Office-based limited facelift
1 of 2
Active Control
Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Limited facelift · No Placebo Group · N/A

Office-based limited faceliftExperimental Group · 5 Interventions: FACE-Q | Aesthetics - Satisfaction With Lower Face and Jawline, FACE-Q | Aesthetics - Recovery Early Symptoms, Limited facelift, FACE-Q | Aesthetics - Adverse Effects: Cheeks, Lower Face, Neck, FACE-Q | Aesthetics - Satisfaction with Outcome · Intervention Types: Other, Other, Procedure, Other, Other
Hospital-based full faceliftActiveComparator Group · 5 Interventions: FACE-Q | Aesthetics - Satisfaction With Lower Face and Jawline, FACE-Q | Aesthetics - Recovery Early Symptoms, FACE-Q | Aesthetics - Adverse Effects: Cheeks, Lower Face, Neck, Full facelift, FACE-Q | Aesthetics - Satisfaction with Outcome · Intervention Types: Other, Other, Other, Procedure, Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: an average of 1 year following surgery
Closest Location: Office of Craig R Dufresne, MD, PC · Fairfax, VA
Photo of Fairfax 1Photo of Fairfax 2Photo of Fairfax 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Facial Asymmetry
0 CompletedClinical Trials

Who is running the clinical trial?

Dufresne, Craig, MD, PCLead Sponsor
3 Previous Clinical Trials
60 Total Patients Enrolled
Craig R Dufresne, MDPrincipal InvestigatorOffice of Dr Craig R Dufresne, MD, PC
3 Previous Clinical Trials
60 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing and able to accept financial responsibilities of undergoing either type of facelift.
You do not have an implanted cardiac device.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.